Lung Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Lung Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-09-03Clinical Trial Update: SCION: SABR and Checkpoint Inhibition of NSCLC [Phase 2]
A Phase 2 trial (SCION) evaluating stereotactic ablative radiotherapy (SABR) with checkpoint inhibition for non-small cell lung cancer has b…
-
CLINICAL_TRIALS withdrawal · 2019-02-04Clinical Trial Update: Retrospective Analysis of the Expression of the Neurotensin Receptor by Metastatic Lung Adenocarcinomas
The clinical trial investigating neurotensin receptor expression in metastatic lung adenocarcinomas has been withdrawn.